Erratum: Engineering a waste management enzyme to overcome cancer resistance to apoptosis: Adding DNase1 to the anti-cancer toolbox (Cancer Gene Therapy (2011) 18 (346-357) DOI: 10.1038/cgt.2010.84);Engineering a waste management enzyme to overcome cancer resistance to apoptosis: Adding DNase1 to the anti-cancer toolbox

Cancer Gene Therapy

Volumn 18, Issue 5, 2011, Pages 346-357

  Rosner, K ^a,b   Kasprzak, M F ^a   Horenstein, A C J ^a   Thurston, H L ^a   Abrams, J ^a   Kerwin, L Y ^a   Mehregan, D A ^b,c   Mehregan, D R ^b,c  

^a KARMANOS CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Pinkus Dermatopathology Laboratory   (United States)

Author keywords

apoptosis; DNase1; melanoma

Indexed keywords

DEOXYRIBONUCLEASE I;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL VIABILITY; DNA FRAGMENTATION; DRUG MECHANISM; GENETIC ENGINEERING; HUMAN; HUMAN CELL; LASER SCANNING CYTOMETRY; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 79954769472     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2011.24     Document Type: Erratum

References (50)

1. Bullani RR, Wehrli P, Viard-Leveugle I, Rimoldi D, Cerottini JC, Saurat JH et al. Frequent downregulation of Fas (CD95) expression and function in melanoma. Melanoma Res 2002; 12: 263-270. (Pubitemid 34666817)
2. Owen-Schaub LB, van Golen KL, Hill LL, Price JE. Fas and Fas ligand interactions suppress melanoma lung metastasis. J Exp Med 1998; 188: 1717-1723. (Pubitemid 28516116)
3. Shin MS, Kim HS, Lee SH, Lee JW, Song YH, Kim YS et al. Alterations of Fas-pathway genes associated with nodal metastasis in non-small cell lung cancer. Oncogene 2002; 21: 4129-4136.
4. Hopkins-Donaldson S, Bodmer JL, Bourloud KB, Brognara CB, Tschopp J, Gross N. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res 2000; 60: 4315-4319. (Pubitemid 32103601)
5. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998; 58: 5315-5320. (Pubitemid 28551107)
6. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 1996; 379: 349-353. (Pubitemid 26033078)
7. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998; 17: 2215-2223. (Pubitemid 28171907)
8. Samejima K, Earnshaw WC. Trashing the genome: the role of nucleases during apoptosis. Nat Rev Mol Cell Biol 2005; 6: 677-688. (Pubitemid 41748063)
9. Kishi K, Yasuda T, Takeshita H. DNase I: structure, fun-ction, and use in medicine and forensic science. Leg Med (Tokyo) 2001; 3: 69-83. (Pubitemid 32663908)
10. Peitsch MC, Muller C, Tschopp J. DNA fragmentation during apoptosis is caused by frequent single-strand cuts. Nucleic Acids Res 1993; 21: 4206-4209. (Pubitemid 23279007)
11. Jones SA, Martin GP, Brown MB. Stabilisation of deoxyr-ibonuclease in hydrofluoroalkanes using miscible vinyl polymers. J Control Release 2006; 115: 1-8. (Pubitemid 44419527)
12. Baranovskii AG, Buneva VN, Nevinsky GA. Human deoxyr-ibonucleases. Biochemistry (Mosc) 2004; 69: 587-601.
13. Doherty AJ, Connolly BA, Worrall AF. Overproduction of the toxic protein, bovine pancreatic DNaseI, in Escherichia coli using a tightly controlled T7-promoter-based vector. Gene 1993; 136: 337-340.
14. Schroter M, Peitsch MC, Tschopp J. Increased p34cdc2-dependent kinase activity during apoptosis: a possible activation mechanism of DNase I leading to DNA break-down. Eur J Cell Biol 1996; 69: 143-150.
15. Bettinger BT, Gilbert DM, Amberg DC Actin up in the nucleus. Nat Rev Mol Cell Biol 2004; 5: 410-415. (Pubitemid 38579478)
16. Eulitz D, Mannherz HG. Inhibition of deoxyribonuclease I by actin is to protect cells from premature cell death. Apoptosis 2007; 12: 1511-1521. (Pubitemid 46988285)
17. Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 2000; 25: 177-181. (Pubitemid 30394988)
18. Shiokawa D, Tanuma S. Characterization of human DNase I family endonucleases and activation of DNase gamma during apoptosis. Biochemistry 2001; 40: 143-152. (Pubitemid 32052685)
19. Nadano D, Yasuda T, Kishi K. Measurement of deoxyr-ibonuclease I activity in human tissues and body fluids by a single radial enzyme-diffusion method. Clin Chem 1993; 39: 448-452. (Pubitemid 23099010)
20. Takeshita H, Mogi K, Yasuda T, Nakajima T, Nakashima Y, Mori S et al. Mammalian deoxyribonucleases I are classified into three types: pancreas, parotid, and pancreas-parotid (mixed), based on differences in their tissue concentrations. Biochem Biophys Res Commun 2000; 269: 481-484. (Pubitemid 30440326)
21. Pan CQ, Lazarus RA. Hyperactivity of human DNase I variants. Dependence on the number of positively charged residues and concentration, length, and environment of DNA. J Biol Chem 1998; 273: 11701-11708. (Pubitemid 28272072)
22. Yang W, Gelles J, Musser SM. Imaging of single-molecule translocation through nuclear pore complexes. Proc Natl Acad Sci USA 2004; 101: 12887-12892. (Pubitemid 39167553)
23. Wu Q, Chen Y, Kulshreshtha V, Tikoo SK. Characterization and nuclear localization of the fiber protein encoded by the late region 7 of bovine adenovirus type 3. Arch Virol 2004; 149: 1783-1799. (Pubitemid 39225269)
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408. (Pubitemid 34164012)
25. Sallai K, Nagy E, Derfalvy B, Muzes G, Gergely P. Antinucleosome antibodies and decreased deoxyribonuclease activity in sera of patients with systemic lupus erythemato-sus. Clin Diagn Lab Immunol 2005; 12: 56-59.
26. Hayashida K, Omagari K, Masuda J, Kohno S. An integrase of endogenous retrovirus is involved in maternal mitochon-drial DNA inheritance of the mouse. Biochem Biophys Res Commun 2008; 366: 206-211. (Pubitemid 50009316)
27. Gorczyca W, Bedner E, Burfeind P, Darzynkiewicz Z, Melamed MR. Analysis of apoptosis in solid tumors by laser-scanning cytometry. Mod Pathol 1998; 11: 1052-1058. (Pubitemid 28525010)
28. Napirei M, Wulf S, Eulitz D, Mannherz HG, Kloeckl T. Comparative characterization of rat deoxyribonuclease 1 (Dnase1) and murine deoxyribonuclease 1-like 3 (Dnase1l3). Biochem J 2005; 389: 355-364. (Pubitemid 41021138)
29. Shak S, Capon DJ, Hellmiss R, Marsters SA, Baker CL. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci USA 1990; 87: 9188-9192. (Pubitemid 120030590)
30. Nishikawa A, Mizuno S. The efficiency of N-linked glycosylation of bovine DNase I depends on the Asn-Xaa-Ser/Thr sequence and the tissue of origin. Biochem J 2001; 355: 245-248. (Pubitemid 32304255)
31. Napirei M, Ricken A, Eulitz D, Knoop H, Mannherz HG. Expression pattern of the deoxyribonuclease 1 gene: lessons from the Dnase1 knockout mouse. Biochem J 2004; 380: 929-937. (Pubitemid 38850536)
32. Shiokawa D, Kobayashi T, Tanuma S. Involvement of DNase gamma in apoptosis associated with myogenic differentiation of C2C12 cells. J Biol Chem 2002; 277: 31031-31037. (Pubitemid 34970807)
33. Nguyen LT, Atobe K, Barichello JM, Ishida T, Kiwada H. Complex formation with plasmid DNA increases the cytotoxi-city of cationic liposomes. Biol Pharm Bull 2007; 30: 751-757. (Pubitemid 46571005)
34. Napirei M, Wulf S, Mannherz HG. Chromatin breakdown during necrosis by serum Dnase1 and the plasminogen system. Arthritis Rheum 2004; 50: 1873-1883. (Pubitemid 38725100)
35. Heere-Ress E, Thallinger C, Lucas T, Schlagbauer-Wadl H, Wacheck V, Monia BP et al. Bcl-X(L) is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy. Int J Cancer 2002; 99: 29-34. (Pubitemid 34273194)
36. Haluska FG, Tsao H, Wu H, Haluska FS, Lazar A, Goel V. Genetic alterations in signaling pathways in melanoma. Clin Cancer Res 2006; 12: 2301s-2307s.
37. Tsao H, Zhang X, Fowlkes K, Haluska FG. Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines. Cancer Res 2000; 60: 1800-1804. (Pubitemid 30207633)
38. Rosner K, Ropke C, Pless V, Skovgaard GL. Late type apoptosis and apoptosis free lethal effect of quercetin in human melanoma. Biosci Biotechnol Biochem 2006; 70: 2169-2177. (Pubitemid 44451894)
39. Martinez-Lorenzo MJ, Anel A, Alava MA, Pineiro A, Naval J, Lasierra P et al. The human melanoma cell line MelJuSo secretes bioactive FasL and APO2 L/TRAIL on the surface of microvesicles. Possible contribution to tumor counter-attack. Exp Cell Res 2004; 295: 315-329. (Pubitemid 38490488)
40. Polzar B, Peitsch MC, Loos R, Tschopp J, Mannherz HG. Overexpression of deoxyribonuclease I (DNase I) transfected into COS-cells: its distribution during apoptotic cell death. Eur J Cell Biol 1993; 62: 397-405. (Pubitemid 24014663)
41. Valdez BC, Perlaky L, Henning D, Saijo Y, Chan PK, Busch H. Identification of the nuclear and nucleolar localization signals of the protein p120. Interaction with translocation protein B23. J Biol Chem 1994; 269: 23776-23783.
42. Liu QY, Ribecco M, Pandey S, Walker PR, Sikorska M. Apoptosis-related functional features of the DNaseI-like family of nucleases. Ann NY Acad Sci 1999; 887: 60-76. (Pubitemid 30040219)
43. Fujihara J, Hieda Y, Xue Y, Nakagami N, Takayama K, Kataoka K et al. One-step purification of mammalian deoxyribonucleases I and differences among pancreas, parotid, and pancreas-parotid (mixed) types based on species-and organ-specific N-linked glycosylation. Biochem-istry (Mosc) 2006; 71(Suppl 1): S65-S70.
44. Pan CQ, Dodge TH, Baker DL, Prince WS, Sinicropi DV, Lazarus RA. Improved potency of hyperactive and actin-resistant human DNase I variants for treatment of cystic fibrosis and systemic lupus erythematosus. J Biol Chem 1998; 273: 18374-18381. (Pubitemid 28334763)
45. Kaina B. DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling. Biochem Pharmacol 2003; 66: 1547-1554. (Pubitemid 38373345)
46. Robles AI, Bemmels NA, Foraker AB, Harris CC. APAF-1 Is a transcriptional target of p53 in DNA damage-induced apoptosis. Cancer Res 2001; 61: 6660-6664. (Pubitemid 32896481)
47. Pan CQ, Ulmer JS, Herzka A, Lazarus RA. Mutational analysis of human DNase I at the DNA binding interface: implications for DNA recognition, catalysis, and metal ion dependence. Protein Sci 1998; 7: 628-636. (Pubitemid 28130885)
48. Al-Hendy A, Auersperg N Applying the herpes simplex virus thymidine kinase/ganciclovir approach to ovarian cancer: an effective in vitro drug-sensitization system. Gynecol Obstet Invest 1997; 43: 268-275. (Pubitemid 27249957)
49. Yang J, Liu TJ, Lu Y. Effects of bicistronic lentiviral vector-mediated herpes simplex virus thymidine kinase/ganciclovir system on human lens epithelial cells. Curr Eye Res 2007; 32: 33-42.
50. Qian C, Idoate M, Bilbao R, Sangro B, Bruna O, Vazquez J et al. Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine- induced hepatocellular carcinoma. Hum Gene Ther 1997; 8: 349-358. (Pubitemid 27412271)